| Bid Price | 0.65p | High Price | 0.69p |
|---|
| Ask Price | 0.70p | Low Price | 0.69p |
|---|
| Open Price | 0.68p | Spread | 7.14% |
|---|
| Prev Close | 0.68p | Volume | 50,000 |
|---|
Physiomics PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Nov 22, 2024 | 0.68 | 0.69 | 0.69 | 0.68 | 50,000 |
| Nov 21, 2024 | 0.68 | 0.70 | 0.69 | 0.68 | 174,292 |
| Nov 20, 2024 | 0.70 | 0.71 | 0.67 | 0.70 | 799,674 |
| Nov 19, 2024 | 0.68 | 0.71 | 0.69 | 0.70 | 1,236,088 |
| Nov 18, 2024 | 0.70 | 0.69 | 0.67 | 0.68 | 1,284,826 |
Physiomics PLC Information
| Name | Physiomics PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00BDR6W943 | Epic | PYC |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASX1 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 150,000 | Trading Status | Closed |
|---|
| Shares in Issue | 203.21 m | Prev Close | 0.68p |
|---|
| PE Ratio | | Market Cap | £1.37 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | £-0.00 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.847268 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 2.865552 | Quick Ratio | 2.441489 |
|---|
Physiomics PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 08/11/24 | BUY | Peter Sargent | CEO | 459,090 @ £0.01 | £3,030.00 |
| 25/07/23 | TOUT | James Millen | CEO | 500,000 @ £0.00 | £0.00 |
| 25/07/23 | TIN | James Millen | CEO | 500,000 @ £0.00 | £0.00 |
| 18/07/23 | TOUT | Christophe Chassagnole | RES | 500,000 @ £0.00 | £0.00 |
| 03/07/23 | PLAC | James Millen | CEO | 500,000 @ £0.00 | £500.00 |
| 22/03/21 | SELL | James Millen | CEO | 2,354 @ £0.00 | £0.00 |
| 22/03/21 | TOUT | James Millen | CEO | 242,287 @ £0.00 | £0.00 |
| 22/03/21 | TIN | James Millen | CEO | 242,287 @ £0.00 | £0.00 |
| 12/08/20 | SELL | James Millen | CEO | 597,332 @ £0.06 | £38,528.00 |
| 05/08/20 | EXR | James Millen | CEO | 1,453,923 @ £0.03 | £36,348.00 |
Physiomics PLC News
